A written assertion was produced from ECDC concerning the sub-version of the Omicron variant of Covid-19, named BQ.1.
It was acknowledged within the assertion that the species in query will grow to be dominant within the EU from mid-November to the start of December, and preliminary laboratory research in Asia have proven that BQ.1 has the flexibility to considerably evade the immune system response.
DOES NOT CAUSE MORE INFECTIONS THAN OTHER VERSIONS
The assertion famous that there was no proof that BQ.1 carries a better threat of an infection when in comparison with the circulating Omicron variants BA.4/BA.5.
Within the assertion, ECDC Director Andrea Ammon acknowledged, “Nations ought to stay vigilant in opposition to the indicators of the emergence and unfold of BQ.1 and proceed delicate testing,” stressing that circumstances ought to be monitored, particularly in individuals over 65 years of age.
Within the assertion, it was reported that the international locations with the best circulation of the species have been France with 19 %, Belgium with 9 %, Eire with 7 %, the Netherlands with 6 % and Italy with 5 %.